• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Quidel Corp.

Quidel wins EUA for COVID-19 test with faster runtime

December 24, 2020 By Sean Whooley

Quidel Corp. (NSDW:QDEL) announced that it received FDA emergency use authorization (EUA) for its Solana SARS-CoV-2 assay. San Diego-based Quidel’s Solana SARS-CoV-2 assay is an isothermal reverse transcriptase-helicase-dependent amplification (RT-HDA) assay designed for the qualitative detection of nucleic acid from the virus causing COVID-19 in nasopharyngeal and nasal swab specimens, according to a news release. Testing […]

Filed Under: Diagnostics, Featured, Food & Drug Administration (FDA), Genomics/Molecular Diagnostics, Regulatory/Compliance Tagged With: coronavirus, COVID-19, FDA, Quidel Corp.

COVID-19 vaccine rally sees testing companies’ stocks dip

November 10, 2020 By Sean Whooley

News of Pfizer and BioNTech’s COVID-19 vaccine candidate performing well has caused markets to rally this week. The two companies are collaborating on a vaccine candidate that has proven in early clinical data to be approximately 90% effective, and the news helped to propel MassDevice’s MedTech 100 Index to a new record high yesterday. However, […]

Filed Under: Business/Financial News, Diagnostics, Featured, Genomics/Molecular Diagnostics, Pharmaceutical, Wall Street Beat Tagged With: Abbott, becton dickinson, BioNTech, coronavirus, COVID-19, Hologic, Pfizer, Quidel Corp., Thermo Fisher Scientific

Report: Some nursing homes refuse to use COVID-19 rapid antigen tests

November 9, 2020 By Sean Whooley

Many rapid COVID-19 tests are going unused in nursing homes as there reportedly remain concerns over accuracy in detecting the virus. The Wall Street Journal reports that a federal survey of nursing homes found that 30% of 13,150 facilities that had rapid testing equipment for at least two weeks did not use it to test […]

Filed Under: Business/Financial News, Contract Manufacturing, Diagnostics, Featured, Genomics/Molecular Diagnostics Tagged With: Abbott, becton dickinson, coronavirus, COVID-19, Quidel Corp.

MedTech 100 roundup: Up-and-down week for industry

August 17, 2020 By Sean Whooley

Medtech stocks highlighted the topsy-turvy nature of the market last week, but ultimately finished the seven days nearly unchanged. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 89.77 points at the end of last week (Aug. 14). Overall, medtech stocks saw a 0.13% increase from the […]

Filed Under: Business/Financial News, Diagnostics, Featured, Genomics/Molecular Diagnostics, MassDevice Earnings Roundup, Mergers & Acquisitions, Research & Development, Wall Street Beat Tagged With: becton dickinson, Celularity, coronavirus, COVID-19, Dept. of Health & Human Services (HHS), Hologic, Livongo, MedTech 100 Index, Medtronic, Qiagen N.V., Quidel Corp., Sanuwave, Senseonics, Thermo Fisher Scientific, Ventec Life Systems, Vingroup

Report: BD, Quidel struggle to supply antigen tests for COVID-19

August 13, 2020 By Nancy Crotti

Becton Dickinson (NYSE:BDX) and Quidel are struggling to fulfill orders for rapid COVID-19 antigen tests as the virus continues to spread, according to a report in the Wall Street Journal. The newspaper reported today that the two companies, which are the only ones that have FDA emergency use authorizations to sell the rapid diagnostics, cannot keep up with […]

Filed Under: Business/Financial News, Diagnostics, Featured, Lab Instruments & Supplies Tagged With: becton dickinson, coronavirus, COVID-19, Quidel Corp.

States band together to purchase BD, Quidel antigen tests for COVID-19

August 5, 2020 By Chris Newmarker

Seven U.S. states have formed an interstate compact with the Rockefeller Foundation to expand the use of rapid point-of-care antigen tests to better manage the COVID-19 pandemic. The compact — announced yesterday by a bipartisan group of governors leading the states — includes Louisiana, Ohio, Maryland, Massachusetts, Michigan, North Carolina and Virginia. The idea is that […]

Filed Under: Business/Financial News, Diagnostics, Featured Tagged With: Becton Dickonson, coronavirus, COVID-19, Quidel Corp.

NIH puts $249m into new COVID-19 tests

July 31, 2020 By Sean Whooley

The National Institutes of Health (NIH) announced today that it is investing $248.7 million in new technologies to address challenges with COVID-19 testing. The “Rapid Acceleration of Diagnostics” (RADx) initiative awarded contracts to seven biomedical diagnostic companies to support lab-based and point-of-care tests that could significantly increase the number, type and availability of tests by […]

Filed Under: Business/Financial News, Diagnostics, Featured, Funding Roundup, Genomics/Molecular Diagnostics Tagged With: coronavirus, COVID-19, Dept. of Health & Human Services (HHS), Fluidigm Corp., Ginkgo Bioworks, Helix OpCo, Mammoth Biosciences, Mesa Biotech, National Institutes of Health (NIH), Quidel Corp., Talis Biomedical

FDA authorizes Quidel antigen test for rapid COVID-19 detection

May 11, 2020 By Chris Newmarker

FDA has issued a first-of-its-kind emergency use authorization for Quidel‘s COVID-19 antigen test, which enables rapid diagnosis of virus infection. San Diego–based Quidel describes the Sofia 2 SARS Antigen FIA as a rapid point-of-care test to be used with the Sofia 2 fluorescent immunoassay analyzer. It can produce results in 15 minutes. Cardinal Health, Fisher […]

Filed Under: Diagnostics, Featured, Food & Drug Administration (FDA), Genomics/Molecular Diagnostics, Regulatory/Compliance Tagged With: coronavirus, COVID-19, FDA, Quidel Corp.

Quest Diagnostics, Quidel Corp. get emergency nod for COVID-19 tests

March 18, 2020 By Nancy Crotti

The FDA has granted two more companies’ COVID-19 tests emergency use authorizations. Tests by  Quest Diagnostics (NYSE:DGX) and Quidel Corp. (NSDW:QDEL) got the nod for distribution within the U.S. without prior clearance or approval. Quest Diagnostics (Secaucus, N.J.) said it will expand testing with its new COVID-19 diagnostic this week from its high-complexity laboratories in Chantilly, Va., […]

Filed Under: Business/Financial News, Diagnostics, Distribution, Featured, Genomics/Molecular Diagnostics Tagged With: coronavirus, FDA, Quest Diagnostics Inc., Quidel Corp.

Abbott launches tender offer for Alere in $5.3B merger

July 17, 2017 By Sarah Faulkner

Abbott (NYSE:ABT) said today that it launched the tender offer for its $5.3 billion acquisition of diagnostics giant Alere (NYSE:ALR). The $402-per-share tender offer is slated to expire at midnight on August 11, Abbott said. The merger was amended in April, when Abbott agreed to pay $5.3 billion for Alere rather than the original price of $5.8 billion. Get […]

Filed Under: Diagnostics, Mergers & Acquisitions, Wall Street Beat Tagged With: Abbott, Alere, Quidel Corp.

Becton Dickinson lands clearance for 10-minute flu test | Regulatory Roundup

January 2, 2012 By MassDevice staff Leave a Comment

Becton Dickinson logo

Becton Dickinson & Co. (NYSE:BDX) won FDA 510(k) clearance for its BD Veritor 10-minute diagnostic test for influenza A and B last month, amid rumors that the Franklin Lakes, N.J.-based company is ripe for buyout.

Veritor is the first rapid flu test with a digital readout, while older tests are slower, less accurate and more difficult to interpret, according to BD.

Filed Under: Diagnostics, News Well Tagged With: Abiomed, becton dickinson, Delcath Systems Inc., EnteroMedics Inc., Magnetecs Corp., MindFrame Inc., Parvulus Swiss SA, Quidel Corp., Sphere Medical Holding plc, Verisante Technology

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS